Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Bioavailability |
72.0 |
% |
72 |
% |
Oral single dose; |
DRUGBANK |
C Max |
22.2 |
ng/ml |
22.2 |
ng/ml |
PO, oral; |
DRUGBANK |
T Max |
1.5 |
h |
1.5 |
h |
PO, oral; BRAF V600 mutation-positive melanoma; |
DRUGBANK |
Clearance |
4.9 |
L/h |
4.9 |
L/h |
apparent clearance; |
DRUGBANK |
Clearance |
0.0480 |
L/h/kg |
0.8 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
214.0 |
L |
214.0 |
L |
Apparent volume of distribution; |
DRUGBANK |
Volume of Distribution |
13.9 |
L/kg |
13.94 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
104.4 |
h |
3.9-4.8 |
day |
elimination half-life; |
DRUGBANK |
Half-life |
229.0 |
h |
229 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
80.0 |
% |
80 |
% |
Faeces excretion; |
DRUGBANK |
Eliminate Route |
0.10 |
% |
<0.1 |
% |
Urinary excretion; |
DRUGBANK |
Protein Binding |
97.4 |
% |
97.4 |
% |
plasma proteins; human, homo sapiens; |
DRUGBANK |